ZADITOR 0.25 MG
KETOTIFEN (KETOTIFEN FUMARATE) : 0.25 MG · DIN 02279223 · NOVARTIS PHARMACEUTICALS CANADA INC
Health Canada status: CANCELLED POST MARKET
What is ZADITOR?
ZADITOR 0.25 MG contains KETOTIFEN (KETOTIFEN FUMARATE) : 0.25 MG. It is listed in the Health Canada Drug Product Database under DIN 02279223, held by NOVARTIS PHARMACEUTICALS CANADA INC, supplied as SOLUTION for OPHTHALMIC administration. Health Canada currently lists it as cancelled post market, status dated 17-Jan-2012. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is ZADITOR used for?
ZADITOR* (ketotifen fumarate ophthalmic solution) is indicated for: treatment of allergic conjunctivitis.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
Product details and regulatory record
| DIN | 02279223 |
|---|---|
| Brand name | ZADITOR |
| Generic / active ingredient | KETOTIFEN (KETOTIFEN FUMARATE) : 0.25 MG |
| Manufacturer | NOVARTIS PHARMACEUTICALS CANADA INC |
| Strength | 0.25 MG |
| Dosage form | SOLUTION |
| Route of administration | OPHTHALMIC |
| Schedule | Prescription |
| ATC code | S01GX08 KETOTIFEN |
| AHFS class | 52:02.00 |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 17-Jan-2012 |
| Original market date | 2006-08-03 00:00:00 |
How is it stored and handled?
Multi dose containers: Store between 4°C and 25°C. Single dose containers: Store between 4°C and 25°C. After opening a blister, unused single dose containers may be stored for 4 weeks. Single dose containers may be stored outside the blister in the outer carton for 3 months.
How is it supplied?
Multi dose containers: 5 mL; Single dose containers: 0.4 mL, Blocks of 5 single dose containers are each packed in a blister. Carton boxes of 30 single dose containers
What can be used instead?
Other Canadian products sharing ATC code S01GX08 KETOTIFEN. 2 of 5 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| JAMP KETOTIFEN OPHTHALMIC | 0.25 MG | SOLUTION | JAMP PHARMA CORPORATION | MARKETED | DIN 02542722 |
| ZADITOR | 0.25 MG | SOLUTION | LABORATOIRES THEA | MARKETED | DIN 02242324 |
| JAMP KETOTIFEN | 0.025 % W/V | SOLUTION | JAMP PHARMA CORPORATION | APPROVED | DIN 02489651 |
| KETOTIFEN OPHTHALMIC SOLUTION | 0.25 MG | SOLUTION | STERIMAX INC | DORMANT | DIN 02400871 |
Who else supplies KETOTIFEN worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. KETOTIFEN appears in 2031 registered pack listings across 10 markets, published on 8 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
Can this still be bought in Canada?
No. This Drug Identification Number is cancelled post market in Health Canada's Drug Product Database, so the product is no longer authorized for sale in Canada and Nexara does not supply it. This page is kept as a regulatory record.
If you are looking for a current equivalent, the alternatives above list every product sharing this therapeutic class, with the marketed ones first. Ask us to source an alternative
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.